Jeffrey Venstrom: We are excited to announce a new research collaboration with Whitman-Walker and Cancer Support Community, aimed at advancing health equity in cancer screening with MCED.
Jeffrey Venstrom, Chief Medical Officer at GRAIL, made the following post on LinkedIn:
“Cancer screening only works if it is accessible to those who need it. Multi-cancer early detection through a simple blood test holds promise for addressing access to screening, but there is more to learn about navigating access barriers, particularly for underserved populations.
We are excited to announce a new research collaboration with Whitman-Walker and Cancer Support Community, aimed at advancing health equity in cancer screening with MCED. The INCLUDE study will evaluate how MCED can be implemented in a diverse, real-world population of underserved patients to increase early cancer detection.”
For details click here.
Source: Jeffrey Venstrom, M.D. / LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023